Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model

Toxicology

Volumn 233, Issue 1-3 SPEC. ISS., 2007, Pages 173-179

  Aurbek, N ^a   Thiermann, H ^a   Szinicz, L ^a   Worek, F ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

Author keywords

Acetylcholinesterase; Human; Model; Organophosphates; Oximes; Pig

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; CHOLINESTERASE REACTIVATOR; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSCARINIC RECEPTOR BLOCKING AGENT; NERVE GAS; OBIDOXIME; ORGANOPHOSPHATE; OXIME DERIVATIVE; PRALIDOXIME;

ARTICLE; CHEMICAL WARFARE; COMPUTER MODEL; ENZYME KINETICS; ENZYME REACTIVATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; SPECIES DIFFERENCE; SWINE; TERRORISM;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE REACTIVATORS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; ORGANOTHIOPHOSPHORUS COMPOUNDS; POISONING; PYRIDINIUM COMPOUNDS; TIME FACTORS;

ANIMALIA; MAMMALIA; SUIDAE;

EID: 33947665139     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.07.001     Document Type: Article

References (36)

1. Aldridge W.N., and Reiner E. Enzyme inhibitors as substrates-interactions of esterases with esters of organophosphorus and carbamic acids (1972), North-Holland Publishing Company, Amsterdam, London
2. Aurbek N., Thiermann H., Szinicz L., Eyer P., and Worek F. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology. 224 (2006) 91-99
3. Aurbek N., Thiermann H., Szinicz L., Eyer P., and Worek F. Application of kinetic-based computer modelling to evaluate the efficacy of HI 6 in percutaneous VX poisoning. Toxicology. 224 (2006) 74-80
4. Baggot J.D. Application of interspecies scaling to the bispyridinium oxime HI-6. Am. J. Vet. Res. 55 (1994) 689-691
5. Benschop H.P., and de Jong L.P.A. Toxicokinetics of nerve agents. In: Somani S.M., and Romano J.A. (Eds). Chemical Warfare Agents: Toxicity at Low Levels (2001), CRC Press, Boca Raton 25-81
6. Bismuth C., Inns R.H., and Marrs T.C. Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Butterworth and Heinemann, Oxford 555-577
7. Chilcott R.P., Dalton C.H., Hill I., Davidson C.M., Blohm K.L., and Hamilton M.G. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Hum. Exp. Toxicol. 22 (2003) 255-261
8. Clement J.G., Bailey D.G., Madill H.D., Tran L.T., and Spence J.D. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine. Biopharm. Drug Dispos. 16 (1995) 415-425
9. Clement J.G., and Erhardt N. In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human. Arch. Toxicol. 68 (1994) 648-655
10. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14 (1994) 317-331
11. Eyer F., and Eyer P. Enzyme-based assay for quantification of paraoxon in blood of parathion poisoned patients. Hum. Exp. Toxicol. 17 (1998) 645-651
12. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 22 (2003) 165-190
13. Green A.L., and Smith H.J. The reactivation of cholinesterase inhibited with organophosphorus compounds. 1. Reactivation by 2-oxoaldoximes. Biochem. J. 68 (1958) 28-31
14. Leader H., Vincze A., Manisterski B., Rothschild N., Dosoretz C., and Ashani Y. Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases. Biochem. Pharmacol. 58 (1999) 503-515
15. Li B., Sedlacek M., Manaharan I., Boopathy R., Duysen E.G., Masson P., and Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70 (2005) 1673-1684
16. Lundy P.M., Hansen A.S., Hand B.T., and Boulet C.A. Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology 72 (1992) 99-105
17. Lundy P.M., Hill I., Lecavalier P., Hamilton M.G., Vair C., Davidson C., Weatherby K.L., and Berger B.J. The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology 208 (2005) 399-409
18. Luo C., Saxena A., Ashani Y., Leader H., Radic Z., Taylor P., and Doctor B.P. Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime. Chem. Biol. Interact. 119/120 (1999) 129-135
19. MacIlwain C. Study proves Iraq used nerve gas. Nature 363 (1993) 3
20. MacPhee-Quigley K., Taylor P., and Taylor S. Primary structures of the catalytic subunits from two molecular forms of acetylcholinesterase-a comparison of NH2-terminal and active center sequences. J. Biol. Chem. 260 (1985) 12185-12189
21. Maxwell D.M., and Brecht K.M. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev. 15 (1991) 135-139
22. Nagao M., Takatori T., Matsuda Y., Nakajima M., Iwase H., and Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 144 (1997) 198-203
23. Shafferman A., Ordentlich A., Barak D., Stein D., Ariel N., and Velan B. Aging of phosphylated human acetylcholinesterase: Catalytic processes mediated by aromatic and polar residues of the active centre. Biochem. J. 318 (1996) 833-840
24. Sidell F.R. Clinical considerations in nerve agent intoxication. In: Somani S.M. (Ed). Chemical Warfare Agents (1992), Academic Press, San Diego 155-194
25. Skrinjaric-Spoljar M., Simeon V., and Reiner E. Spontaneous reactivation and aging of dimethylphosphorylated acetylcholinesterase and cholinesterase. Biochim. Biophys. Acta 315 (1973) 363-369
26. Su C.T., Wang P.H., Lui R.F., Shih J.H., Ma C., Lin C.H., Liu C.Y., and Wu M.T. Kinetic studies and structure-activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Fundam. Appl. Toxicol. 6 (1986) 506-514
27. Szinicz L., and Kullmann R. Therapie der Vergiftungen mit hochtoxischen organischen Phosphorverbindungen. Wehrmed. Mschr. 34 (1990) 176-181
28. Taylor P., Radic Z., Hosca N.A., Camp S., Marchot P., and Berman H.A. Structural basis for the specificity of cholinesterase catalysis and inhibition. Toxicol. Lett. 82/83 (1995) 453-458
29. Thiermann H., Szinicz L., Eyer F., Worek F., Eyer P., Felgenhauer N., and Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol. Lett. 107 (1999) 233-239
30. van der Schans M.J., Lander B.J., van der Wiel H., Langenberg J.P., and Benschop H.P. Toxicokinetics of the nerve agent (±)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191 (2003) 48-62
31. Volans A.P. Sarin: guidelines on the management of victims of a nerve gas attack. J. Accid. Emerg. Med. 13 (1996) 202-206
32. Worek F., Bäcker M., Thiermann H., Szinicz L., Mast U., Klimmek R., and Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 16 (1997) 466-472
33. Worek F., Diepold C., and Eyer P. Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch. Toxicol. 73 (1999) 7-14
34. Worek F., Reiter G., Eyer P., and Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch. Toxicol. 76 (2002) 523-529
35. Worek F., Szinicz L., Eyer P., and Thiermann H. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model. Toxicol. Appl. Pharmacol. 209 (2005) 193-202
36. Worek F., Thiermann H., Szinicz L., and Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol. 68 (2004) 2237-2248